Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
Olaniyi Ayobami, Niklas Willrich, Thomas Harder, et al.
Emerging Microbes & Infections (2019) Vol. 8, Iss. 1, pp. 1747-1759
Open Access | Times Cited: 124

Showing 26-50 of 124 citing articles:

Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions
Wafaa H. Elwakil, Soha S. Rizk, Ali M. El-Halawany, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 77-77
Open Access | Times Cited: 12
Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii
Natalia Kolesnik-Goldmann, Helena M. B. Seth-Smith, Klara Haldimann, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1212-1212
Open Access | Times Cited: 12
Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis
Margaret Toluwalayo Arowolo, Oluwatosin Qawiyy Orababa, Morufat Oluwatosin Olaitan, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0287762-e0287762
Open Access | Times Cited: 11
Microbial Air Quality in Healthcare Facilities
Lucia Bonadonna, Rossella Briancesco, Anna Maria Coccia, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 12, pp. 6226-6226
Open Access | Times Cited: 26
Application of Antimicrobial Photodynamic Therapy for Inactivation of Acinetobacter baumannii Biofilms
Irina Buchovec, Enrika Vyčaitė, Kazimieras Badokas, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 722-722
Open Access | Times Cited: 16
Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia
Rayan I Aloraifi, Abdullah F. Alharthi, Abdulrahman A Almefleh, et al.
Cureus (2023)
Open Access | Times Cited: 10
Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Causing Nosocomial Meningitis in the Neurological Intensive Care Unit
Nadezhda K. Fursova, Mikhail V. Fursov, Evgeny I. Astashkin, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2020-2020
Open Access | Times Cited: 9
Exploring the antimicrobial activity of Origanum majorana L. against the highly virulent multidrug-resistant Acinetobacter baumannii AB5075: UPLC-HRMS profiling with in vitro and in silico studies
Norhan H. Mahdally, Abdalla E. M. Salih, Riham A. El‐Shiekh, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan
Wail Hayajneh, Sayer Al‐Azzam, Dawood Yusef, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 2, pp. 524-530
Open Access | Times Cited: 25
OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response
Jūratė Skerniškytė, Emilija Karazijaitė, Asta Lučiūnaitė, et al.
Pathogens (2021) Vol. 10, Iss. 4, pp. 407-407
Open Access | Times Cited: 22
Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel blaADC-257
Mai M. Zafer, Amira F. A. Hussein, Mohamed H. Al‐Agamy, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 22
WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective
Gamal Wareth, Christian Brandt, Lisa Sprague, et al.
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility
Yanpeng Zhang, Bing Fan, Yong Luo, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps
Shruti Kashyap, Sukhvir Kaur, Prince Sharma, et al.
Microbes and Infection (2021) Vol. 23, Iss. 4-5, pp. 104795-104795
Closed Access | Times Cited: 20
Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
Sílvia A. Sousa, Joana R. Feliciano, Tiago Pita, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 942-942
Open Access | Times Cited: 20
Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study
Dewi Anggraini, Dewi Santosaningsih, Yulia Rosa Saharman, et al.
Antibiotics (2022) Vol. 11, Iss. 3, pp. 366-366
Open Access | Times Cited: 15
Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures
Shuk‐Ching Wong, Pui Hing Chau, Simon Yung-Chun So, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1076-1076
Open Access | Times Cited: 14
An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan
Yu‐Chia Hsieh, Jia-Wen Wu, Yiyin Chen, et al.
Antibiotics (2021) Vol. 10, Iss. 10, pp. 1239-1239
Open Access | Times Cited: 19
Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring blaNDM and blaOXA From Clinical Origin
Hasan Ejaz, Mahtab Ahmad, Sonia Younas, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1931-1939
Open Access | Times Cited: 18
Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance
Liping Zhao, Xixi Guo, Zhimeng Zhang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 10, pp. 109506-109506
Closed Access | Times Cited: 2
Characterization of the diversity of type IV secretion system-encoding plasmids in Acinetobacter
Farah Nasser, Avery Gaudreau, Shareefah Lubega, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Medical Importance of ESKAPE Pathogens
Simi Asma Salim, Mahima S. Mohan, Nishel Forgia, et al.
(2024), pp. 1-32
Closed Access | Times Cited: 2
Structure of a Rhs effector clade domain provides mechanistic insights into type VI secretion system toxin delivery
Brooke K. Hayes, Marina Harper, Hariprasad Venugopal, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Global travel and Gram-negative bacterial resistance; implications on clinical management
Nicolette Theriault, Glenn Tillotson, Christian E. Sandrock
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 181-196
Closed Access | Times Cited: 18
Genetic, antimicrobial resistance profile and mortality rates of Acinetobacter baumannii infection in Brazil: A systematic review
Mirian CB. Silva, Maria HB. Werlang, Deborah F. Vandresen, et al.
Narra J (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12

Scroll to top